microMRS-MED
Non-invasive embryo selection for IVF
UnknownActive
Key Facts
About Annaida Technologies
Annaida Technologies is pioneering microscale Magnetic Resonance Spectroscopy (MRS) to transform metabolic data into actionable insights for personalized medicine. Founded in 2016 and based in Zug, Switzerland, the company has developed a proprietary, patent-protected platform that analyzes living samples at the nanolitre scale without labels or disruption. It operates a dual business model, offering both dedicated medical devices (microMRS-MED) for fertility clinics and research tools/services (microMRS-LAB/TUBE) for life sciences, positioning itself at the intersection of medical devices, AI-driven diagnostics, and research tools.
View full company profile